Norgestimate
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (February 2007) |
| Systematic (IUPAC) name | |
|---|---|
| (13-ethyl-17-ethynyl-3-hydroxyimino- 1,2,6,7,8,9,10,11,12,14,15,16- dodecahydrocyclopenta[a] phenanthren-17-yl) acetate | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601050 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Half-life | 12-30 hours |
| Identifiers | |
| CAS number | 35189-28-7 |
| ATC code | G03AA11 G03FA13 (only combinations with estrogens) |
| PubChem | CID 6540478 |
| DrugBank | DB00957 |
| ChemSpider | 5022837 |
| UNII | C291HFX4DY |
| KEGG | D05209 |
| ChEBI | CHEBI:50815 |
| ChEMBL | CHEMBL1200934 |
| Chemical data | |
| Formula | C23H31NO3 |
| Mol. mass | 369.497 g/mol |
|
|
|
|
| |
|
Norgestimate is a molecule used in hormonal contraceptives.
Norgestimate is a form of progestin, which is a female hormone important for the regulation of ovulation and menstruation. Norgestimate is used with estradiol (a female sex hormone that is involved in the development and maintenance of the female reproductive system), to treat the symptoms of menopause.
Norgestimate and ethinylestradiol are used as an oral contraceptive, indicated for the prevention of pregnancy in women.
See also [edit]
|
||||||||||||||||||||||||||||||||
| This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |